Veronesi U, Salvadori B, Luini A, Banfi A, Zucali R, Del Vecchio M, Saccozzi R, Beretta E, Boracchi P, Farante G
Instituto Nazionale per lo Studio e la Cura dei Tumori Via Venezian, Milan, Italy.
Ann Surg. 1990 Mar;211(3):250-9.
One thousand two hundred and thirty-two women with invasive breast cancer lesions measuring less than 2 cm in diameter, clinically assessed as T1N0-1M0, were treated from 1970 to 1983 at the National Cancer Institute of Milan with quadrantectomy, axillary dissection, and radiotherapy (QUART). Pathologic evidence of lymph-nodes metastases was found in 32% of the patients. Overall survival at 5 and 10 years from surgery was 91% and 78%, respectively. The cumulative probability of survival tends to decrease with increasing tumor size: the 7-year survival rate was 84% in cases in which lesions measured from 1.6 to 2.0 cm, and 94% in cases in which the lesions were less than 0.5 cm. Tumor site in the treated breast did not affect distant outcome. No difference was found between the patients without node metastases and patients with one node involved, whereas the patients with more than one node showed a lower probability of survival. The survival curves of 352 cases treated inside a randomized trial and that of 880 cases routinely treated appear to be superimposable. Local recurrences and new primary ipsilateral tumors were, respectively, 35 (2.8%) and 19 (1.6%); 56 women with local recurrences or second tumors underwent second surgery (total mastectomy, 43; wide resection, 11). Five of them died from distant spread of breast cancer, while 49 are alive and well. In the contralateral breasts 45 carcinomas were recorded during the follow-up time. The results of the present analysis of a large number of T1 cases reconfirm the safety of integrated radiosurgical conservative treatments.
1970年至1983年期间,米兰国家癌症研究所对1232例直径小于2 cm、临床评估为T1N0-1M0的浸润性乳腺癌病变女性患者进行了象限切除术、腋窝清扫术和放疗(QUART)。32%的患者有淋巴结转移的病理证据。手术后5年和10年的总生存率分别为91%和78%。生存率的累积概率倾向于随着肿瘤大小的增加而降低:病变大小在1.6至2.0 cm的病例中,7年生存率为84%;病变小于0.5 cm的病例中,7年生存率为94%。治疗乳房的肿瘤部位不影响远处转归。未发现无淋巴结转移患者与有一个淋巴结受累患者之间存在差异,而有一个以上淋巴结受累的患者生存率较低。在一项随机试验中治疗的352例患者和常规治疗的880例患者的生存曲线似乎是重叠的。局部复发和同侧新发原发性肿瘤分别为35例(2.8%)和19例(1.6%);56例有局部复发或第二肿瘤的女性接受了二次手术(全乳房切除术43例;广泛切除术11例)。其中5例死于乳腺癌远处转移,49例存活且情况良好。在随访期间,对侧乳房记录到45例癌。对大量T1病例的当前分析结果再次证实了综合放射外科保守治疗的安全性。